Fiera Capital Corp Sells 33,071 Shares of OR Royalties Inc. $OR

Fiera Capital Corp decreased its position in OR Royalties Inc. (NYSE:OR) by 8.6% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 349,922 shares of the basic materials company’s stock after selling 33,071 shares during the quarter. Fiera Capital Corp owned 0.19% of OR Royalties worth $12,399,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also added to or reduced their stakes in the company. Assetmark Inc. bought a new stake in OR Royalties in the 4th quarter worth approximately $36,000. Caitlin John LLC bought a new position in OR Royalties in the 3rd quarter valued at $78,000. Allworth Financial LP grew its position in OR Royalties by 20.0% in the 4th quarter. Allworth Financial LP now owns 2,305 shares of the basic materials company’s stock valued at $82,000 after acquiring an additional 384 shares during the last quarter. Merit Financial Group LLC bought a new position in OR Royalties in the 3rd quarter valued at $215,000. Finally, Flow Traders U.S. LLC bought a new position in OR Royalties in the 3rd quarter valued at $217,000. Institutional investors own 68.52% of the company’s stock.

Analysts Set New Price Targets

Several brokerages have commented on OR. TD Securities reaffirmed a “hold” rating on shares of OR Royalties in a research report on Monday, February 23rd. Zacks Research downgraded OR Royalties from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, March 31st. Royal Bank Of Canada reaffirmed an “outperform” rating and issued a $56.00 price objective on shares of OR Royalties in a research report on Friday, April 10th. Wall Street Zen cut OR Royalties from a “buy” rating to a “hold” rating in a report on Saturday. Finally, Weiss Ratings cut OR Royalties from a “buy (b)” rating to a “buy (b-)” rating in a report on Thursday. One analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating and four have assigned a Hold rating to the stock. Based on data from MarketBeat, OR Royalties currently has an average rating of “Moderate Buy” and a consensus price target of $46.50.

OR Royalties Stock Performance

Shares of OR opened at $33.84 on Tuesday. The company has a 50 day moving average price of $38.02 and a 200-day moving average price of $38.75. OR Royalties Inc. has a fifty-two week low of $24.76 and a fifty-two week high of $48.06. The stock has a market capitalization of $6.34 billion, a PE ratio of 25.25 and a beta of 0.70.

OR Royalties (NYSE:OR) last announced its quarterly earnings results on Wednesday, May 6th. The basic materials company reported $0.40 earnings per share for the quarter, topping the consensus estimate of $0.34 by $0.06. OR Royalties had a net margin of 78.09% and a return on equity of 15.10%. The firm had revenue of $102.83 million during the quarter, compared to analysts’ expectations of $103.27 million. Equities research analysts forecast that OR Royalties Inc. will post 1.4 EPS for the current year.

OR Royalties Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 15th. Investors of record on Tuesday, June 30th will be given a dividend of $0.065 per share. The ex-dividend date of this dividend is Tuesday, June 30th. This is an increase from OR Royalties’s previous quarterly dividend of $0.06. This represents a $0.26 dividend on an annualized basis and a yield of 0.8%. OR Royalties’s dividend payout ratio is 16.42%.

OR Royalties Company Profile

OR Royalties PLC (NYSE: OR) is a closed-ended investment company that specializes in acquiring and managing royalty interests in life science and pharmaceutical products. The company provides capital to biotechnology, specialty pharmaceutical and medical device companies in exchange for a share of future sales revenues. By focusing on royalties secured against marketed products, OR Royalties aims to deliver income and growth potential while minimizing the development and commercialization risks typically associated with direct equity stakes.

The company’s core activities include sourcing royalty transactions, structuring bespoke financing solutions and actively monitoring a diversified portfolio of assets.